Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis | HTML
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients - Kidney International Reports
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
Immunoglobulin‐free light chain monomer‐dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: A pilot study - Kaplan - 2014 - American Journal of Hematology - Wiley Online Library
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
Immunoglobulin Kappa Chain - an overview | ScienceDirect Topics
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains - ScienceDirect
Different immunoreactivity of monomers and dimers makes automated free light chains assays not equivalent | Semantic Scholar
○ Serum Free Light Chains -血清遊離輕鏈 - ☆ 優活 健康網 ☆ Living Well Website
Frontiers | High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | SpringerLink
Overestimation of Serum κ Free Light Chain Concentration by Immunonephelometry
Measurement of kappa () and lambda () light chains in free and total... | Download High-Quality Scientific Diagram
Serum free light chain immunoassays and their clinical application - ScienceDirect
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica